1970; ():   
© The Korean Society of Neurogastroenterology and Motility. All rights reserved.

References
  1. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol 2002;167(2 Pt 2):1197-203; discussion 1204.
  2. Marmor MF, Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 1999;44:153-62.
  3. Jang YS, Ahn GS, Kim SD. Retinal hemorrhage associated with viagra (sildenafil citrate). J Korean Ophthalmol Soc 2002;43:1340-4.
  4. Lee WJ, Seong M. Bilateral simultaneous acute angle closure glaucoma following sexual intercourse aided by sildenafil citrate. J Korean Ophthalmol Soc 2011;52:1123-7.
  5. Jung YH, Lee NY, Yim HB. A case of inferior rectus muscle enlargement after taking sildenafil citrate. J Korean Ophthalmol Soc 2013;54:382-6.
  6. Jeon YH, Heo YS, Kim CM, et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005;62:1198220.
  7. Lagnado L. The Wellcome Prize Lecture. Visual signals in the retina:from photons to synapses. Exp phyisiol 2000;85:1-16.
  8. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002;168(4 Pt 1):1332-6.
  9. Bella AJ, Brant WO, Lue TF, Brock GB. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors. Can J Urol 2006;13:3233-8.
  10. Fraunfelder FW, Pomeranz HD, Egan RA. Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch ophthalmol 2006;124:733-4.


This Article

e-submission

Archives

Aims and Scope